#NHS Scotland spinout aiming to further accelerate growth with Boston Congress presence - an exciting opportunity for @innoscothealth investment @aurumbioscience https://t.co/STAEariDPA
An article from Aurum's Chairman on how @innoscothealth can help support innovation in the NHS. Aurum has received significant support from InnoScot Health on its journey to the clinic.
Scottish biopharmaceutical company and InnoScot Health spin-out @aurumbioscience has been invited to speak at BioTrinity 2024 on 24 April, allowing it to demonstrate the potential of its technology to advance the management of acute stroke patients.
👉 https://t.co/91Wc82Chx0
Aurum Biosciences have been invited to present at #Biotrinity. CEO Dr David Brennan will be sharing details of Aurum's groundbreaking clinical technology and its use in areas of high unmet medical need.
https://t.co/n5OPQd6TmL
A spinout of InnoScot Health, @NHSGGC and @UofGlasgow, @aurumbioscience is developing a novel drug for therapeutics and multiple diagnostics, in areas of unmet clinical need such as stroke, spinal cord injury, and inflammatory imaging.
Read more 👉 https://t.co/91Wc82Chx0
Ahead of securing almost £730,000 in funding, @aurumbioscience announced that it had been recognised by the UK’s Innovative Licensing and Access Pathway for ABL-101 and awarded an Innovation Passport, a gateway to the accelerative pathway.
Read more 👉 https://t.co/I7gs9zU7Is
Scottish biopharmaceutical company @aurumbioscience has raised almost £730,000 in the first tranche of a new round of funding aimed at further developing its state-of-the-art therapeutic and diagnostic technology and setting up fresh success in 2024.
👉 https://t.co/I7gs9zU7Is
NEWS: Biopharmaceutical company @aurumbioscience raises almost £730k in first tranche of new equity round aimed at further developing its state-of-the-art therapeutic and diagnostic technology. @scotent is among investors ➡️
https://t.co/dPcoO5vPxU
New on our website @posleadership, Executive Chair of InnoScot Health, discusses the necessity for NHS Scotland to retain commercially astute healthcare professionals 👉 https://t.co/M2wcehVWdo
The award of the Innovation Passport is recognition that @aurumbioscience's patented ABL-101 platform technology has the potential to offer the first major advancement in the management of acute stroke patients in more than two decades.
Read more 👉 https://t.co/1SaLBpCEaD
🏅 Exciting news for #Glasgow's biopharmaceutical sector!
@aurumbioscience has been awarded an Innovation Passport by the UK's Innovative Licensing and Access Pathway for their groundbreaking stroke technology
👇 Read & Comment
https://t.co/zCIgKzrKQV
#Glasgow#Scotland
Glasgow spinout, @aurumbioscience, has been awarded an Innovation Passport for it's state-of-the-art stroke technology 👏
The recognition by the UK’s Innovative Licensing & Access Pathway will help acceletate the firm's tech to market 📈
#ScotlandIsNow
https://t.co/zWsmJFdVeP
Huge congratulations to Glasgow spinout @aurumbioscience on being awarded an Innovation Passport for its state-of-the-art stroke technology 👏
The 'passport' will help accelerate the commercialisation of the firm's life-saving technology 📈
#Innovation
https://t.co/LiIaXlpyUA
.@aurumbioscience, a clinical stage biopharmaceutical company based in Scotland, spun out by InnoScot Health, @NHSGGC and @UofGlasgow, has been awarded an Innovation Passport for its breakthrough stroke technology.
Read more 👉 https://t.co/1SaLBpCEaD
Business Briefing:
◾Hairy Bikers to help boost food, drink tourism in Scotland
◾Scottish stroke treatment pioneer Aurum appoints new chief
◾Scottish firm harnessing artificial intelligence to build workforce
👉https://t.co/pglvkYzMox